| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |